Literature DB >> 33766692

Browning white adipose tissue using adipose stromal cell-targeted resveratrol-loaded nanoparticles for combating obesity.

Yujiao Zu1, Ling Zhao2, Lei Hao1, Yehia Mechref3, Masoud Zabet-Moghaddam4, Peter A Keyel5, Mehrnaz Abbasi6, Dayong Wu7, John A Dawson8, Ruiwen Zhang9, Shufang Nie1, Naima Moustaid-Moussa1, Mikhail G Kolonin10, Alexes C Daquinag10, Luis Brandi11, Irfan Warraich11, Susan K San Francisco12, Xiaocun Sun13, Zhaoyang Fan14, Shu Wang15.   

Abstract

Enhancing thermogenic energy expenditure via promoting the browning of white adipose tissue (WAT) is a potential therapeutic strategy to manage energy imbalance and the consequent comorbidities associated with excess body weight. Adverse effects and toxicities of currently available methods to induce browning of WAT have retarded exploration of this promising therapeutic approach. Targeted delivery of browning agents to adipose stromal cells (ASCs) in subcutaneous WAT to induce differentiation into beige adipocytes may overcome these barriers. Herein, we report for the first time, ASC-targeted delivery of trans-resveratrol (R), a representative agent, using ligand-coated R-encapsulated nanoparticles (L-Rnano) that selectively bind to glycanation site-deficient decorin receptors on ASCs. After biweekly intravenous administration of L-Rnano to obese C57BL/6 J mice for 5 weeks targeted R delivery significantly induced ASCs differentiation into beige adipocytes, which subsequently resulted in 40% decrease in fat mass, accompanied by improved glucose homeostasis and decreased inflammation. Our results suggest that the ASC-targeted nanoparticle delivery of browning agents could be a transformative technology in combating obesity and its comorbidities with high efficacy and low toxicity.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adipose stromal cells; Beige adipocytes; Nanoparticles; Obesity; trans-resveratrol

Mesh:

Substances:

Year:  2021        PMID: 33766692      PMCID: PMC8396108          DOI: 10.1016/j.jconrel.2021.03.022

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   11.467


  63 in total

Review 1.  Concise review: Adipose-derived stromal vascular fraction cells and stem cells: let's not get lost in translation.

Authors:  Jeffrey M Gimble; Bruce A Bunnell; Ernest S Chiu; Farshid Guilak
Journal:  Stem Cells       Date:  2011-05       Impact factor: 6.277

Review 2.  Role of immune cells in obesity induced low grade inflammation and insulin resistance.

Authors:  Ambreen Asghar; Nadeem Sheikh
Journal:  Cell Immunol       Date:  2017-03-07       Impact factor: 4.868

Review 3.  Inflammation of brown/beige adipose tissues in obesity and metabolic disease.

Authors:  F Villarroya; R Cereijo; A Gavaldà-Navarro; J Villarroya; M Giralt
Journal:  J Intern Med       Date:  2018-07-16       Impact factor: 8.989

4.  Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures.

Authors:  C Olbrich; R H Müller
Journal:  Int J Pharm       Date:  1999-03-25       Impact factor: 5.875

Review 5.  Resveratrol in metabolic health: an overview of the current evidence and perspectives.

Authors:  Morten Møller Poulsen; Jens Otto Lunde Jørgensen; Niels Jessen; Bjørn Richelsen; Steen Bønløkke Pedersen
Journal:  Ann N Y Acad Sci       Date:  2013-07       Impact factor: 5.691

6.  Survey of the trans-resveratrol and trans-piceid content of cocoa-containing and chocolate products.

Authors:  W Jeffrey Hurst; Jan A Glinski; Kenneth B Miller; Joan Apgar; Matthew H Davey; David A Stuart
Journal:  J Agric Food Chem       Date:  2008-08-30       Impact factor: 5.279

7.  Thermogenic adipocytes promote HDL turnover and reverse cholesterol transport.

Authors:  Alexander Bartelt; Clara John; Nicola Schaltenberg; Jimmy F P Berbée; Anna Worthmann; M Lisa Cherradi; Christian Schlein; Julia Piepenburg; Mariëtte R Boon; Franz Rinninger; Markus Heine; Klaus Toedter; Andreas Niemeier; Stefan K Nilsson; Markus Fischer; Sander L Wijers; Wouter van Marken Lichtenbelt; Ludger Scheja; Patrick C N Rensen; Joerg Heeren
Journal:  Nat Commun       Date:  2017-04-19       Impact factor: 14.919

Review 8.  Anatomical locations of human brown adipose tissue: functional relevance and implications in obesity and type 2 diabetes.

Authors:  Harold Sacks; Michael E Symonds
Journal:  Diabetes       Date:  2013-06       Impact factor: 9.461

9.  Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.

Authors:  Jimmy F P Berbée; Mariëtte R Boon; P Padmini S J Khedoe; Alexander Bartelt; Christian Schlein; Anna Worthmann; Sander Kooijman; Geerte Hoeke; Isabel M Mol; Clara John; Caroline Jung; Nadia Vazirpanah; Linda P J Brouwers; Philip L S M Gordts; Jeffrey D Esko; Pieter S Hiemstra; Louis M Havekes; Ludger Scheja; Joerg Heeren; Patrick C N Rensen
Journal:  Nat Commun       Date:  2015-03-10       Impact factor: 14.919

10.  Associations between tissue visfatin/nicotinamide, phosphoribosyltransferase (Nampt), retinol binding protein-4, and vaspin concentrations and insulin resistance in morbidly obese subjects.

Authors:  Zeynep Goktas; Shannon Owens; Mallory Boylan; David Syn; Chwan-Li Shen; Debra B Reed; Susan San Francisco; Shu Wang
Journal:  Mediators Inflamm       Date:  2013-12-03       Impact factor: 4.711

View more
  3 in total

Review 1.  Nanomedicine of Plant Origin for the Treatment of Metabolic Disorders.

Authors:  Fang Hu; Dong-Sheng Sun; Kai-Li Wang; Dan-Ying Shang
Journal:  Front Bioeng Biotechnol       Date:  2022-02-11

Review 2.  Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities.

Authors:  Jing Li; Hongli Duan; Yan Liu; Lu Wang; Xing Zhou
Journal:  Pharmaceutics       Date:  2022-07-11       Impact factor: 6.525

Review 3.  A Review on Obesity Management through Natural Compounds and a Green Nanomedicine-Based Approach.

Authors:  Monika Bhardwaj; Poonam Yadav; Divya Vashishth; Kavita Sharma; Ajay Kumar; Jyoti Chahal; Sunita Dalal; Sudhir Kumar Kataria
Journal:  Molecules       Date:  2021-05-28       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.